oninvasive brain stimulation for attention deficits after traumatic brain injury

Phase 2

Completed

• Conditions: Attention deficits after traumatic brain injury; Injury, Occupational Diseases, Poisoning

• Registration Number: ISRCTN55243064
• Lead Sponsor: Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal

Brief Summary

2021 results in https://pubmed.ncbi.nlm.nih.gov/34059152/ (added 02/06/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-02-01
• Study Start: 2020-10-15
• Last Update Posted: 14 June 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

1. Current hospitalization
2. Age 18 years old or more
3. Diagnosis of mild complicated, moderate or severe TBI
4. Attentional impairment as per qualitative clinical assessment
5. French or English speaking
6. Tolerance to 45 to 60 minutes neuropsychology evaluation
7. Capacity to consent in accordance with the Nova Scotia Hospitals Act

Exclusion Criteria

1. History of neurological disease not resulting from the current TBI (e.g., stroke, multiple sclerosis, neurodegenerative disorders)
2. Psychiatric illness (e.g., depression, schizophrenia, anxiety disorders)
3. Aphasia and compromises in understanding instructions
4. Significant deafness or blindness
5. Contraindication to tDCS (e.g., seizure, extensive cranial vault lesion, pregnancy or breastfeeding, pacemaker, cochlear implants or cerebral metal implanted device or clip)
6. Scar or skull deformity at the site of electrodes placement
7. Epileptogenic medication
8. Penetrating TBI

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Tolerance, adverse effects and safety measured using a customized questionnaire adapted from those provided by Brunoni et al. at the end of each stimulation